Skip to main content
. 2019 Apr 2;14(4):e0214462. doi: 10.1371/journal.pone.0214462

Table 3. Odds ratios of lung cancer occurrence in relation to genotypes in the C1 metabolism genes, in study population from northern Poland.

Polymorphism Genotype Lung cancer cases
(% of genotype carriers)
Controls
(% of genotype carriers)
OR (95% CI), P
rs1801133
MTHFR c.665C>T
CC 65 (49) 158 (40) 1 (Ref)
CT 55 (42) 199 (50) 0.66 (0.43–1.01), P = 0.056
TT 12 (9) 39 (10) 0.75 (0.37–1.51), P = 0.423
P for trend = 0.120
TvsCC(Ref) 0.68 (0.45–1.01), P = 0.057
TTvsC(Ref) 0.92 (0.47–1.80), P = 0.801
rs1801131
MTHFR c.1286A>C
AA 69 (52) 193 (49) 1 (Ref)
AC 49 (37) 169 (43) 0.80 (0.53–1.23), P = 0.314
CC 14 (11) 34 (9) 1.16 (0.59–2.29), P = 0.665
P for trend = 0.818
CvsAA(Ref) 0.87 (0.59–1.29), P = 0.482
CCvsA(Ref) 1.27 (0.65–2.45), P = 0.484
CBS c.844_845ins68 DD 110 (83) 343 (87) 1 (Ref)
I allele 22 (17) 53 (13) 1.32 (0.75–2.31), P = 0.338
rs1979277
SHMT1 c.1420C>T
CC 53 (40) 164 (41) 1 (Ref)
CT 61 (46) 186 (47) 1.02 (0.66–1.57), P = 0.935
TT 18 (14) 46 (12) 1.22 (0.64–2.31), P = 0.546
P for trend = 0.618
TvsCC(Ref) 1.06 (0.70–1.59), P = 0.794
TTvsC(Ref) 1.21 (0.67–2.18), P = 0.535
rs2236225
MTHFD1 c.1958G>A
GG 39 (30) 131 (33) 1 (Ref)
GA 63 (48) 182 (46) 1.15 (0.74–1.80), P = 0.530
AA 30 (23) 83 (21) 1.21 (0.70–2.09), P = 0.496
P for trend = 0.470
AvsGG(Ref) 1.17 (0.77–1.78), P = 0.463
AAvsG(Ref) 1.11 (0.69–1.78), P = 0.669
rs1801394
MTRR c.66A>G
GG 50 (38) 119 (30) 1 (Ref)
GA 58 (44) 190 (48) 1.09 (0.63–1.87), P = 0.768
AA 24 (18) 87 (22) 1.50 (0.87–2.60), P = 0.148
P for trend = 0.115
AvsGG(Ref) 0.70 (0.47–1.06), P = 0.095
AAvsG(Ref) 0.79 (0.48–1.30), P = 0.359
rs1805087
MTR c.2756A>G
AA 91 (69) 245 (62) 1 (Ref)
AG 36 (27) 133 (34) 0.73 (0.47–1.13), P = 0.162
GG 5 (4) 18 (5) 0.75 (0.27–2.10), P = 0.587
P for trend = 0.178
GvsAA(Ref) 0.73 (0.48–1.12), P = 0.148
GGvsA(Ref) 0.83 (0.30–2.28), P = 0.710
rs202243265
rs11280056
rs16430
TYMS 3'UTR ins/del
II 67 (51) 179 (45) 1 (Ref)
ID 61 (46) 184 (46) 0.88 (0.59–1.33), P = 0.547
DD 4 (3) 33 (8) 0.33 (0.11–0.96), P = 0.041
P for trend = 0.079
3*DvsII(Ref) 0.80 (0.53–1.19), P = 0.261
3*DDvsI(Ref) 0.35 (0.12–1.00), P = 0.050
TYMS 5'UTR 2R/3R 2R/2R 32 (24) 72 (18) 1 (Ref)
2R/3R 66 (50) 205 (52) 0.716 (0.43–1.18), P = 0.189
3R/3R 34 (26) 119 (30) 0.62 (0.34–1.12), P = 0.112
P for trend = 0.120
5' 3Rvs2R2R(Ref) 0.69 (0.42–1.11), P = 0.125
5' 3R3R vs2R(Ref) 0.80 (0.51–1.26), P = 0.333
DHFR c.86+60_78ins22 II 36 (27) 119 (30) 1 (Ref)
ID 72 (55) 198 (50) 1.22 (0.76–1.95), P = 0.414
DD 24 (18) 79 (20) 1.01 (0.56–1.80), P = 0.985
P for trend = 0.886
DvsII(Ref) 1.15 (0.74–1.79), P = 0.541
DDvsI(Ref) 0.89 (0.54–1.48), P = 0.659
rs1801198
TCN2 c.776C>G
CC 39 (30) 125 (32) 1 (Ref)
CG 64 (48) 183 (46) 1.12 (0.71–1.75), P = 0.634
GG 29 (22) 88 (22) 1.05 (0.61–1.82), P = 0.850
P for trend = 0.810
GvsCC(Ref) 1.10 (0.72–1.67), P = 0.670
GGvsC(Ref) 0.99 (0.62–1.58), P = 0.952
rs61510559
SLC19A1 c.80G>A
GG 35 (27) 115 (29) 1 (Ref)
GA 68 (52) 191 (48) 1.17 (0.73–1.87), P = 0.514
AA 29 (22) 90 (23) 1.06 (0.60–1.88), P = 0.834
P for trend = 0.803
AvsGG(Ref) 1.14 (0.72–1.78), P = 0.574
AAvsG(Ref) 0.96 (0.60–1.54), P = 0.857
rs61510559
SLC19A1 c.80G>A
Women
GG 11 (18) 57 (31) 1 (Ref)
GA 31 (51) 95 (52) 1.72 (0.80–3.73), P = 0.168
AA 19 (31) 31 (17) 3.14 (1.32–7.46), P = 0.010
P for trend = 0.009
AvsGG (Ref) 2.08 (1.00–4.31), P = 0.050
AAvsG (Ref) 2.16 (1.12–4.17), P = 0.022
rs61510559
SLC19A1 c.80G>A
Men
GG 24 (34) 58 (27) 1 (Ref)
GA 37 (52) 96 (45) 0.90 (0.49–1.66), P = 0.740
AA 10 (14) 59 (28) 0.39 (0.17–0.91), P = 0.030
P for trend = 0.040
AvsGG (Ref) 0.73 (0.40–1.31), P = 0.284
AAvsG (Ref) 0.42 (0.20–0.88), P = 0.022